newsfilter
← Latest News
Business Wire·

Adagio Medical Receives IDE Approval from the FDA to Investigate Next-Generation vCLAS® Ventricular Ablation System

Designed to Deliver Faster, More Efficient Ablation with Improved Usability on Established, Titratable, Endocardial-Approach ULTA Platform Adagio Medical Holdings, Inc. (NASDAQ:ADGM) ("Adagio" or "the Company"), a